About Apcer Life Sciences India Limited
Data last updated:
Apcer Life Sciences India Limited is a public limited company based in Santacruz West, Maharashtra, India, a subsidiary of Apcer Life Sciences Ltd. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 16 March 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2009PLC190958. Its GSTIN is 27AAHCA6482E1ZL (Maharashtra). The company holds 6 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It was formerly known as Apcer Pharma India Limited. It is led by directors including Ravindra Krishnadas Pasta and Tejus Menon Ravindra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 040 Vikas Centre 106 S.V. Road, Santacruz West, Maharashtra, India – 400054.
As per the financials filed for FY 2025, the company reported a revenue of ₹148.38 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹12.48 Cr (net margin 8.4%) and EBITDA of ₹20.03 Cr (EBITDA margin 13.5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 7% over five years.
The company is associated with 1 brand: APCER Life Sciences. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 3 deals on record (3 secondary share transfers); the latest was in October 2018. The company has 7 MSME Form 1 returns on record between 2018 and 2023, listing 43 overdue payments to 4 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apcerls.com.
Company details
Contact details
Apcer Life Sciences India Limited's registered office is in Santacruz West, Maharashtra. Its website is apcerls.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressG – 040 Vikas Centre 106 S.V. Road, Santacruz West, Maharashtra, India – 400054
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Apcer Life Sciences India Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Apcer Life Sciences India operates one associated brand: APCER Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers pharmacovigilance, medical information, and regulatory affairs services to biotech firms worldwide. | apcerls.com |
Business activity
The main business activity of Apcer Life Sciences India is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Apcer Life Sciences India Limited, buy the company report.
Financials of Apcer Life Sciences India Limited
FY 2025 filings availableApcer Life Sciences India Limited reported revenue of ₹148.38 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 7% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20.03 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.48 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.5% | ||||
| Net Profit Margin | 8.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Apcer Life Sciences India Limited, buy the company report.
Board of directors of Apcer Life Sciences India Limited
Apcer Life Sciences India has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravindra Krishnadas Pasta Also directs: Yika Pharmacare LLP, Apc Pharmaceuticals and Chemicals Private Limited, Apc Nutrients Private Limited and 1 more | Director | 16 Mar 2009 | 17 Years 7 Months | Current |
| Tejus Menon Ravindra Also directs: Apc Nutrients Private Limited | Director | 16 Jan 2019 | 7 Years 9 Months | Current |
| Ravindra Narayan Menon Also directs: Yika Pharmacare LLP, Apc Pharmaceuticals and Chemicals Private Limited, Apc Nutrients Private Limited and 1 more | Director | 16 Mar 2009 | 17 Years 7 Months | Current |
| Nishant Mohan Menon Also directs: Yika Pharmacare LLP, Apc Pharmaceuticals and Chemicals Private Limited, Metta Life Sciences Private Limited and 2 more | Director | 16 Jul 2024 | 2 Years 3 Months | Current |
Auditor
Apcer Life Sciences India Limited is audited by S.M. Pradhan & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.M. Pradhan & Co. | FY 2023 | 108039W |
Shareholding
The shareholding of Apcer Life Sciences India Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Apcer Life Sciences India Limited, buy the company report.
Deals & funding
Apcer Life Sciences India Limited has 3 deals on record (3 secondary share transfers); the latest was in October 2018.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2018 | Secondary share transfer | Undisclosed | Buyer: Apcer Life Sciences Limited & Umesh Potdar Seller: Apcer Life Sciences Limited & Tejus Menon |
| Aug 2017 | Secondary share transfer | Undisclosed | Buyer: Apcer Life Sciences Limited & Tejus Menon, Apcer Life Sciences Limited & Divya Menon Seller: Apcer Life Sciences Limited & Navita Srinet, Apcer Life Sciences Limited & Umesh Potdar |
| Nov 2009 | Secondary share transfer | Undisclosed | Buyer: Apcer Life Sciences Limited & Mohan Menon, Apcer Life Sciences Limited & Chetan Dave, Apcer Life Sciences Ltd Seller: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Apcer Life Sciences India Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Pending |
To see the full case history of Apcer Life Sciences India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Apcer Life Sciences India Limited has 7 MSME Form 1 returns on record between 2018 and 2023, listing 43 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| TM Solutech Private Limited | |||
| an individual supplier | |||
| Avcom Infotech Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Apcer Life Sciences India Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Apcer Life Sciences India has 6 GST registrations: 5 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCA6482E1ZL | Maharashtra | Active | 01 Jul 2017 |
| 24AAHCA6482E1ZR | Gujarat | Active | 01 Jul 2017 |
| 07AAHCA6482E2ZM | Delhi | Active | 24 Jul 2017 |
| 09AAHCA6482E1ZJ | Uttar Pradesh | Active | 19 Feb 2025 |
To see the full GST registrations and return filing status of Apcer Life Sciences India Limited, buy the company report.
Recent activity
Apcer Life Sciences India Limited has 8 board changes on record since 2009: 4 appointments and 4 cessations. The latest: Nishant Mohan Menon ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Apcer Life Sciences India is an active public limited company based in Santacruz West, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 16 March 2009 (17+ years old) and is registered under CIN U51397MH2009PLC190958.
Apcer Life Sciences India has 4 current directors:
- Ravindra Krishnadas Pasta - Director
- Tejus Menon Ravindra - Director
- Ravindra Narayan Menon - Director
- Nishant Mohan Menon - Director
The latest financial statements of Apcer Life Sciences India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Apcer Life Sciences India is 27AAHCA6482E1ZL, registered in Maharashtra. The company has 6 GST registrations in all, of which 5 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAHCA6482E1ZR (Gujarat), 07AAHCA6482E2ZM (Delhi), 09AAHCA6482E1ZJ (Uttar Pradesh).
The CIN (Corporate Identification Number) of Apcer Life Sciences India is U51397MH2009PLC190958. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apcer Life Sciences India has 1 court case on record: 1 filed against it. 1 is pending.
Apcer Life Sciences India was incorporated on 16 March 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
Apcer Life Sciences India has 3 deals on record (3 secondary share transfers); the latest was in October 2018.
Nishant Mohan Menon ceased to be Additional Director on 29 Sep 2024. Nishant Mohan Menon was appointed as Director on 16 Jul 2024. Tejus Menon Ravindra ceased to be Additional Director on 30 Sep 2019. Apcer Life Sciences India has 8 board changes on record in total.
Apcer Life Sciences India has 7 MSME Form 1 returns on record between 2018 and 2023, listing 43 overdue payments to 4 micro and small suppliers. The latest return was filed on 30 Aug 2023.
Apcer Life Sciences India can be reached through the website apcerls.com. Its registered office is in Santacruz West, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
